Pharm-话题@MedSci

#Pharm#

730篇内容 | 2592人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787597, encodeId=24c51e8759738, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Forendo Pharma成功完成FOR-6219的1a期临床试验，用于治疗子宫内膜异位症, objectType=article, longId=161876, objectId=6f061618e6bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f061618e6bb, replyNumber=0, likeNumber=60, createdTime=2019-05-02, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f061618e6bb, moduleTitle=Forendo Pharma成功完成FOR-6219的1a期临床试验，用于治疗子宫内膜异位症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f061618e6bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787615, encodeId=4e391e8761523, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展, objectType=article, longId=174474, objectId=94081e4474dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94081e4474dd, replyNumber=0, likeNumber=59, createdTime=2019-10-29, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94081e4474dd, moduleTitle=Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94081e4474dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787606, encodeId=da571e87606c0, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, objectType=article, longId=164907, objectId=fe4216490eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4216490eae, replyNumber=0, likeNumber=58, createdTime=2019-06-06, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4216490eae, moduleTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4216490eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787589, encodeId=33791e87589e6, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Curr Pharm Des：他汀类药物在非酒精性脂肪性肝病治疗中的作用, objectType=article, longId=160565, objectId=a4b716056511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4b716056511, replyNumber=0, likeNumber=62, createdTime=2019-04-04, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4b716056511, moduleTitle=Curr Pharm Des：他汀类药物在非酒精性脂肪性肝病治疗中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4b716056511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787630, encodeId=9b151e87630a3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究, objectType=article, longId=178845, objectId=88551e8845db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88551e8845db, replyNumber=0, likeNumber=71, createdTime=2020-02-11, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88551e8845db, moduleTitle=头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88551e8845db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787580, encodeId=f1e41e8758066, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡, objectType=article, longId=159495, objectId=60281594950a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60281594950a, replyNumber=0, likeNumber=53, createdTime=2019-04-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60281594950a, moduleTitle=Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60281594950a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787594, encodeId=bf521e87594a5, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur J Pharm Sci：色苷酸交联壳聚糖纳米粒子治疗过敏性鼻炎的效果研究, objectType=article, longId=161591, objectId=9b9f1615911b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b9f1615911b, replyNumber=0, likeNumber=98, createdTime=2019-12-21, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b9f1615911b, moduleTitle=Eur J Pharm Sci：色苷酸交联壳聚糖纳米粒子治疗过敏性鼻炎的效果研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b9f1615911b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787609, encodeId=552b1e87609cb, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：含有氧化石墨烯的可注射热敏水凝胶有效促进成骨, objectType=article, longId=165274, objectId=29741652e48b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29741652e48b, replyNumber=0, likeNumber=58, createdTime=2019-06-13, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29741652e48b, moduleTitle=Biomed Pharmacother：含有氧化石墨烯的可注射热敏水凝胶有效促进成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29741652e48b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787621, encodeId=af8e1e87621ab, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=FDA指控Strides Pharma Science印度工厂存在"重大违规行为", objectType=article, longId=175748, objectId=0b8f1e574862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b8f1e574862, replyNumber=0, likeNumber=93, createdTime=2019-09-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b8f1e574862, moduleTitle=FDA指控Strides Pharma Science印度工厂存在"重大违规行为", moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b8f1e574862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787601, encodeId=f3501e8760142, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症, objectType=article, longId=163702, objectId=69dd163e02ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69dd163e02ec, replyNumber=0, likeNumber=71, createdTime=2020-03-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69dd163e02ec, moduleTitle=Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69dd163e02ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787604, encodeId=ebe41e87604d2, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Myr Pharma的bulevirtide阻断NTCP，在HBV/HDV合并感染患者中展现出强大的抗病毒作用, objectType=article, longId=164358, objectId=b7c5164358c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7c5164358c6, replyNumber=0, likeNumber=80, createdTime=2020-02-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7c5164358c6, moduleTitle=Myr Pharma的bulevirtide阻断NTCP，在HBV/HDV合并感染患者中展现出强大的抗病毒作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7c5164358c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787564, encodeId=e7a41e8756481, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy：冠心病：他汀联用ACEI还是ARB更有效？, objectType=article, longId=156867, objectId=2b1a15686e00, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b1a15686e00, replyNumber=0, likeNumber=47, createdTime=2019-05-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b1a15686e00, moduleTitle=Pharmacotherapy：冠心病：他汀联用ACEI还是ARB更有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b1a15686e00)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787569, encodeId=60681e87569c0, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci：miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎, objectType=article, longId=157192, objectId=78f115e19289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f115e19289, replyNumber=0, likeNumber=50, createdTime=2019-03-20, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f115e19289, moduleTitle=Eur Rev Med Pharmacol Sci：miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78f115e19289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787592, encodeId=80241e875926c, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Hansa Biopharma宣布欧洲药品管理局接受IDEFIRIX（imlifidase）用于高度敏感的肾移植患者的营销授权申请, objectType=article, longId=161543, objectId=416d16154305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=416d16154305, replyNumber=0, likeNumber=46, createdTime=2019-12-03, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=416d16154305, moduleTitle=Hansa Biopharma宣布欧洲药品管理局接受IDEFIRIX（imlifidase）用于高度敏感的肾移植患者的营销授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=416d16154305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787625, encodeId=ae881e8762559, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败, objectType=article, longId=177158, objectId=67421e715857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67421e715857, replyNumber=0, likeNumber=65, createdTime=2019-12-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67421e715857, moduleTitle=Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67421e715857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787614, encodeId=33b61e8761451, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合, objectType=article, longId=168540, objectId=a263168540ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a263168540ab, replyNumber=0, likeNumber=64, createdTime=2020-04-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a263168540ab, moduleTitle=Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a263168540ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787610, encodeId=e77d1e8761072, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究, objectType=article, longId=165386, objectId=e65f1653861d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e65f1653861d, replyNumber=0, likeNumber=70, createdTime=2019-12-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e65f1653861d, moduleTitle=Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e65f1653861d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787618, encodeId=28651e8761871, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=FDA批准Karyopharm的核输出抑制剂Xpovio用于治疗复发或难治的多发性骨髓瘤, objectType=article, longId=174802, objectId=d82e1e480215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82e1e480215, replyNumber=0, likeNumber=68, createdTime=2020-03-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82e1e480215, moduleTitle=FDA批准Karyopharm的核输出抑制剂Xpovio用于治疗复发或难治的多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82e1e480215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787612, encodeId=03b61e8761234, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, objectType=article, longId=166721, objectId=b315166e2142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b315166e2142, replyNumber=0, likeNumber=48, createdTime=2019-10-16, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b315166e2142, moduleTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b315166e2142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787624, encodeId=b59b1e876241f, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用, objectType=article, longId=176577, objectId=2b9d1e65771e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b9d1e65771e, replyNumber=0, likeNumber=64, createdTime=2020-06-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b9d1e65771e, moduleTitle=Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b9d1e65771e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Forendo Pharma成功完成FOR-6219的1a期临床试验，用于治疗子宫内膜异位症

2019-05-02

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展

2019-10-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可

2019-06-06

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Curr Pharm Des：他汀类药物在非酒精性脂肪性肝病治疗中的作用

2019-04-04

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究

2020-02-11

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡

2019-04-19

智智灵药 (审核中...)

前往app查看评论内容

#Pharm#

Eur J Pharm Sci：色苷酸交联壳聚糖纳米粒子治疗过敏性鼻炎的效果研究

2019-12-21

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：含有氧化石墨烯的可注射热敏水凝胶有效促进成骨

2019-06-13

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

FDA指控Strides Pharma Science印度工厂存在"重大违规行为"

2019-09-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症

2020-03-19

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Myr Pharma的bulevirtide阻断NTCP，在HBV/HDV合并感染患者中展现出强大的抗病毒作用

2020-02-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacotherapy：冠心病：他汀联用ACEI还是ARB更有效？

2019-05-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur Rev Med Pharmacol Sci：miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎

2019-03-20

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Hansa Biopharma宣布欧洲药品管理局接受IDEFIRIX（imlifidase）用于高度敏感的肾移植患者的营销授权申请

2019-12-03

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：cinaciguat联合胰岛素治疗可有效治疗糖尿病造成的种植失败

2019-12-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合

2020-04-19

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究

2019-12-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

FDA批准Karyopharm的核输出抑制剂Xpovio用于治疗复发或难治的多发性骨髓瘤

2020-03-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法

2019-10-16

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用

2020-06-21

科室
- - 订阅+
  - 更多科室
工具
服务